Cost-effective to screen all women for breast cancer genes: study
Genetic testing for all women over 30 would prevent millions of deaths from breast and ovarian cancer globally and be cost effective in medium and higher income countries. That is the conclusion of international research published in the journal Cancers, looking at the economic case for population-level screening for the BRCA1 and BRCA2 gene mutations. Breast …